What Is Bourbon Virus? Symptoms, Risk, and a Possible Treatment Breakthrough
Bourbon virus is a rare but potentially serious tick-borne illness with no approved treatment. New research suggests a possible antiviral therapy—but human data are still limited.
Rare infection.
Severe symptoms.
No proven treatment—yet.
Most people have never heard of Bourbon virus.
But for those infected, it can be serious—and even fatal.
What Is Bourbon Virus?
Bourbon virus is a tick-borne infection identified in the United States, primarily in the Midwest and southern regions.
It is considered rare, but cases may be underrecognized due to limited testing availability.
Like other tick-borne infections, it is associated with tick exposure and nonspecific symptoms.
Bourbon Virus Symptoms
- Fever
- Fatigue
- Muscle aches
- Nausea or vomiting
- Rash
Severe cases may lead to hospitalization and death.
In one reported case, a patient died after 23 days despite supportive care.
Is There a Treatment for Bourbon Virus?
Currently, no approved treatment exists.
This is one of the major concerns with Bourbon virus.
Management is typically supportive, focusing on symptoms rather than targeting the virus directly.
A Possible Treatment Breakthrough
Researchers studied the antiviral drug favipiravir in a mouse model.
“Without treatment, 100% of infected mice died. With treatment, 100% survived.”
Even when treatment was started after symptoms began:
- Mice stopped losing weight
- Recovery began quickly
- All treated animals survived
This suggests a potential future therapy—but human studies are needed.
Why Bourbon Virus Matters
Bourbon virus highlights a broader issue:
- Emerging tick-borne diseases are increasing
- Many lack reliable testing
- Treatment options remain limited
This is similar to challenges seen in Lyme disease testing and other infections.
Clinical Takeaway
Bourbon virus is rare—but potentially severe—and currently lacks approved treatment.
Early recognition and awareness are critical as research continues.
Start Here
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
